NovMetaPharma Co (XKRX:229500) EV-to-Revenue : 1,941.99 (As of Jun. 04, 2025)

NovMetaPharma Co EV-to-Revenue Chart

NovMetaPharma Co Annual Data
	Trend	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EV-to-Revenue		Get a 7-Day Free Trial					4,918.15	2,628.08	3,683.17	16,007.46	1,233.20

NovMetaPharma Co Semi-Annual Data
	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EV-to-Revenue	Get a 7-Day Free Trial					4,918.15	2,628.08	3,683.17	16,007.46	1,233.20

Competitive Comparison of NovMetaPharma Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, NovMetaPharma Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NovMetaPharma Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NovMetaPharma Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where NovMetaPharma Co's EV-to-Revenue falls into.

NovMetaPharma Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

NovMetaPharma Co's EV-to-Revenue for today is calculated as:

NovMetaPharma Co's current Enterprise Value is ₩88,001.24 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. NovMetaPharma Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was ₩45.32 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NovMetaPharma Co  (XKRX:229500) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

NovMetaPharma Co's PS Ratiofor today is calculated as:

NovMetaPharma Co's share price for today is ₩7350.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2024 was ₩4.08.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NovMetaPharma Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of NovMetaPharma Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

NovMetaPharma Co Business Description